Reply: `Antitumor activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone.

Aurelius Omlin, Carmel Jo Pezaro, Shane Zaidi, David Lorente, Deborah Mukherji, Diletta Bianchini, Roberta Ferraldeschi, Shahneen K Sandhu, David P Dearnaley, Christopher Parker, Nicholas Van As, Johann S De Bono, Gerhardt Attard

Research output: Contribution to journalLetterOther

Original languageEnglish
Pages (from-to)267 - 268
Number of pages2
JournalBritish Journal of Cancer
Publication statusPublished - 2014
Externally publishedYes

Cite this